iBio, Inc. Common Stock
IBIO
$0.78+0.26%
End of day · as of Oct 16, 2026, 8:30 AM ET
Mkt cap
$13.38M
EV/Sales
-430.14
P/E ratio
N/A
FY2026 Revenue
$100,000
EPS (9mo ended 2026-03-31)
$-0.25
Gross Margin (FY2026)
N/A
Profit Margin (FY2026)
-32840.00%
Beta
0.94
Div yield
N/A
Sector
Healthcare
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Use this IBIO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IBIO income, balance, and cash tables.
iBio, Inc. Common Stock (IBIO) is a biotechnology company in the Healthcare sector.
Latest cached iBio, Inc. Common Stock (IBIO) revenue for Jun 30, 2026 was $100.0K. Net income was -$32.8M. Statements: https://lician.com/financials/ibio
iBio, Inc. Common Stock (IBIO) market capitalization is $13.4M on the latest cached snapshot.
iBio, Inc. Common Stock (IBIO) cached previous close $0.78; day range $0.78 – $0.82; volume 345,672. Session quote: https://lician.com/quote/ibio
iBio, Inc. Common Stock (IBIO) latest cached earnings event is "IBIO earnings" on Sep 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IBIO filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/ibio